Hemodynamic Effects of Sodium-Glucose Cotransporter 2 Inhibitors.

about

Direct cardiovascular impact of SGLT2 inhibitors: mechanisms and effects.Heart failure risk and major cardiovascular events in diabetes: an overview of within-group differences in non-insulin antidiabetic treatment.

P2860

Q47739163-32C9C556-1A9B-492D-B515-AFAD3826F1F9 Q48274537-EF248FA0-3800-429C-A72E-C893BC69C529

P2860

Hemodynamic Effects of Sodium-Glucose Cotransporter 2 Inhibitors.

Item

http://www.wikidata.org/entity/Q39300236

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Hemodynamic Effects of Sodium-Glucose Cotransporter 2 Inhibitors.

@en

Hemodynamic Effects of Sodium-Glucose Cotransporter 2 Inhibitors.

@nl

type

Item

label

Hemodynamic Effects of Sodium-Glucose Cotransporter 2 Inhibitors.

@en

Hemodynamic Effects of Sodium-Glucose Cotransporter 2 Inhibitors.

@nl

prefLabel

Hemodynamic Effects of Sodium-Glucose Cotransporter 2 Inhibitors.

@en

Hemodynamic Effects of Sodium-Glucose Cotransporter 2 Inhibitors.

@nl

P1476

Hemodynamic Effects of Sodium-Glucose Cotransporter 2 Inhibitors.

@en

P2093

Motoaki Sano

http://www.w3.org/2001/XMLSchema#string

P2860

Increased Hematocrit During Sodium-Glucose Cotransporter 2 Inhibitor Therapy Indicates Recovery of Tubulointerstitial Function in Diabetic Kidneys

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.

Dysfunction of fibroblasts of extrarenal origin underlies renal fibrosis and renal anemia in mice

Diabetic Cardiomyopathy: Mechanisms and Therapeutic Targets.

Dose-finding study of luseogliflozin in Japanese patients with type 2 diabetes mellitus: a 12-week, randomized, double-blind, placebo-controlled, phase II study.

Efficacy and safety of luseogliflozin monotherapy in Japanese patients with type 2 diabetes mellitus: a 12-week, randomized, placebo-controlled, phase II study.

Acute SGLT inhibition normalizes O2 tension in the renal cortex but causes hypoxia in the renal medulla in anaesthetized control and diabetic rats.

Efficacy and safety of luseogliflozin as monotherapy in Japanese patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled, phase 3 study.

Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes.

P304

457-460

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.14740/JOCMR3011W

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-04-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28496544

http://www.w3.org/2001/XMLSchema#string

P921

hemodynamics

glycobiology

P932

5412517

http://www.w3.org/2001/XMLSchema#string

Hemodynamic Effects of Sodium-Glucose Cotransporter 2 Inhibitors.

about

P2860

P2860

Hemodynamic Effects of Sodium-Glucose Cotransporter 2 Inhibitors.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932